166 related articles for article (PubMed ID: 12100177)
1. Imiquimod: a potential role in dermatology?
Eedy DJ
Br J Dermatol; 2002 Jul; 147(1):1-6. PubMed ID: 12100177
[No Abstract] [Full Text] [Related]
2. [Imiquimod--a substance with a broad working spectrum].
Oster-Schmidt C
J Dtsch Dermatol Ges; 2004 Oct; 2(10):821-2. PubMed ID: 16281584
[No Abstract] [Full Text] [Related]
3. Imiquimod: a cytokine inducer.
Dahl MV
J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S205-8. PubMed ID: 12271278
[No Abstract] [Full Text] [Related]
4. Recent therapeutic advances in dermatology.
Lipper GM; Arndt KA; Dover JS
JAMA; 2000 Jan; 283(2):175-7. PubMed ID: 10634322
[No Abstract] [Full Text] [Related]
5. [Proven and promising for the future].
Steinhorst M
Hautarzt; 2001 Jan; 52(1):p following 90 (92). PubMed ID: 11220250
[No Abstract] [Full Text] [Related]
6. Imiquimod; an international update on therapeutic uses in dermatology.
Tyring S; Conant M; Marini M; Van Der Meijden W; Washenik K
Int J Dermatol; 2002 Nov; 41(11):810-6. PubMed ID: 12453012
[TBL] [Abstract][Full Text] [Related]
7. Imiquimod for genital warts.
Med Lett Drugs Ther; 1997 Dec; 39(1016):118-9. PubMed ID: 9422045
[No Abstract] [Full Text] [Related]
8. FDA approval of imiquimod cream in treatment of STD warts.
AIDS Patient Care STDS; 1997 Oct; 11(5):377-8. PubMed ID: 11361830
[No Abstract] [Full Text] [Related]
9. Imiquimod: an immune response modifier.
Dahl MV
J Am Acad Dermatol; 2000 Jul; 43(1 Pt 2):S1-5. PubMed ID: 10861100
[No Abstract] [Full Text] [Related]
10. Imiquimod in dermatology: an overview.
Hanna E; Abadi R; Abbas O
Int J Dermatol; 2016 Aug; 55(8):831-44. PubMed ID: 27387373
[TBL] [Abstract][Full Text] [Related]
11. Off-label indications for imiquimod.
Ganjian S; Ourian AJ; Shamtoub G; Wu JJ; Murase JE
Dermatol Online J; 2009 May; 15(5):4. PubMed ID: 19624982
[TBL] [Abstract][Full Text] [Related]
12. New treatments for genital warts less than ideal: abstract and commentary.
Fife KH
JAMA; 1998 Jun; 279(24):2003-4. PubMed ID: 9643868
[No Abstract] [Full Text] [Related]
13. Imiquimod in clinical practice.
Edwards L
J Am Acad Dermatol; 2000 Jul; 43(1 Pt 2):S12-7. PubMed ID: 10861102
[TBL] [Abstract][Full Text] [Related]
14. [Imiquimod--clinical efficacy].
Beutner KR
Ann Dermatol Venereol; 2000; 127(10 Suppl):3S19-3S21. PubMed ID: 11116859
[No Abstract] [Full Text] [Related]
15. Topical imiquimod therapy for external anogenital warts in pregnant women.
Audisio T; Roca FC; Piatti C
Int J Gynaecol Obstet; 2008 Mar; 100(3):275-6. PubMed ID: 18035356
[No Abstract] [Full Text] [Related]
16. Successful treatment of anogenital Bowen's disease with the immunomodulator imiquimod, and monitoring of therapy by DNA image cytometry.
Gutzmer R; Kaspari M; Vogelbruch M; Kiehl P; Kapp A; Werfel T; Brodersen JP
Br J Dermatol; 2002 Jul; 147(1):160-5. PubMed ID: 12100202
[TBL] [Abstract][Full Text] [Related]
17. Warts treatment.
Treat Rev; 1995 Nov; (no 20):7. PubMed ID: 11363030
[TBL] [Abstract][Full Text] [Related]
18. Beyond a decade of 5% imiquimod topical therapy.
A Gaspari A; Tyring SK; Rosen T
J Drugs Dermatol; 2009 May; 8(5):467-74. PubMed ID: 19537370
[TBL] [Abstract][Full Text] [Related]
19. New therapy update: ALDARA (imiquimod cream, 5%).
Abramovits W; Gupta AK
Skinmed; 2004; 3(4):215. PubMed ID: 15249782
[No Abstract] [Full Text] [Related]
20. The use of topical 5% imiquimod during pregnancy: a case series.
Einarson A; Costei A; Kalra S; Rouleau M; Koren G
Reprod Toxicol; 2006 Jan; 21(1):1-2. PubMed ID: 16039826
[No Abstract] [Full Text] [Related]
[Next] [New Search]
